Pfizer ' s COVID-19 Treatment Paxlovid Will No Longer Be Available For Emergency Use After This Date, FDA Revises Label

The FDA has updated the emergency use authorization (EUA) for Pfizer Inc’s PFE Paxlovid, impacting its distribution and use in treating mild-to-moderate COVID-19. In December 2021, the FDA authorized Paxlovid for emergency use for the treatment of adults and pediatric patients who are at high risk…#fda #eua #pfizerincs #pfepaxlovid #pfizer #nda #ndalabeledpaxlovid #providers #paxcess #medicare
Source: Reuters: Health - Category: Consumer Health News Source Type: news